Send to

Choose Destination
See comment in PubMed Commons below
Magy Onkol. 2002;46(3):203-23. Epub 2002 Oct 6.

[Cost-effective PET investigations in oncology].

[Article in Hungarian]

Author information

PET Centrum, Debreceni Egyetem Orvos-és Egészségtudományi Centrum, Altalános Orvostudományi Kar, Debrecen, 4026, Hungary.


The authors have reviewed the financial considerations of oncological FDG PET examinations by the guidelines of the Health Care Financing Administration (USA). By critical assessment of large number of clinical investigations,the cost-effectiveness of FDG PET scans has been confirmed in the following cases: differential diagnosis of solitary pulmonary nodule, diagnosis,staging and restaging of non-small cell lung cancer, colorectal cancer, malignant lymphomas, melanoma malignum, esophageal neoplasms and cancers of the head and neck. The role of this method in breast cancer is currently under intensive investigation. Due to the correct staging, PET examinations in these indications enable the clinicians to choose the optimal treatment ensuring the maximum probability of recovery and being cost-effective as unnecessary medical interventions become avoidable.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hungarian Oncological Association
    Loading ...
    Support Center